Introduction: (i) Cardiovascular disease (CVD), particularly coronary heart disease (CHD) and stroke, are the leading cause of morbidity and mortality worldwide; (ii) Dyslipidaemia is an important but modifiable cardiovascular risk factor. For instance, Familial Hypercholesterolaemia (FH) is a monogenic autosomal condition where patients present very high LDL-C values and an increase cardiovascular risk; (iii) FH is caused by mutations in 3 genes: LDLR, APOB and PCSK9. However in only about 40%-50% of the cases an FH causing mutation is found.N/
textabstractFamilial hypercholesterolemia (FH) is an autosomal dominant disorder of lipid metabolism...
amilial hypercholesterolaemia (FH) is a monogenic disorder of low-density lipoprotein (LDL) metaboli...
Familial Hypercholesterolaemia (FH) is genetic disorder touching up to 1 to 250 people, increasing t...
Familial hypercholesterolaemia (FH) is a monogenic autosomal condition where patients present very ...
Familial Hypercholesterolaemia (FH) is a monogenic lipid disorder caused by mutations in LDLR, APOB,...
Cardiovascular disease (CVD) remains the most common cause of death globally. Dyslipidaemia is one o...
Familial hypercholesterolemia (FH) is the most frequent genetic disease and is characterized by elev...
Background: Autosomal dominant hypercholesterolemia (ADH) is known to be a major risk factor for car...
Familial Hypercholesterolemia (FH) is a genetic autosomal dominant disorder characterized clinically...
Familial Hypercholesterolaemia (FH) is the commonest autosomal co-dominantly inherited condition af...
The clinical phenotype of heterozygous familial hypercholesterolemia (FH) is characterized by increa...
Background: Clinically, Familial Hypercholesterolaemia (FH) is characterized by high plasma concentr...
textabstractFamilial hypercholesterolemia (FH) (OMIM #143890) is an autosomal dominant disorder pres...
Aim: Genetic diagnosis is the only method to correctly identify patients with Familial hypercholest...
Familial Hypercholesterolaemia (FH) is a monogenic disorder characterised by high LDL-C concentratio...
textabstractFamilial hypercholesterolemia (FH) is an autosomal dominant disorder of lipid metabolism...
amilial hypercholesterolaemia (FH) is a monogenic disorder of low-density lipoprotein (LDL) metaboli...
Familial Hypercholesterolaemia (FH) is genetic disorder touching up to 1 to 250 people, increasing t...
Familial hypercholesterolaemia (FH) is a monogenic autosomal condition where patients present very ...
Familial Hypercholesterolaemia (FH) is a monogenic lipid disorder caused by mutations in LDLR, APOB,...
Cardiovascular disease (CVD) remains the most common cause of death globally. Dyslipidaemia is one o...
Familial hypercholesterolemia (FH) is the most frequent genetic disease and is characterized by elev...
Background: Autosomal dominant hypercholesterolemia (ADH) is known to be a major risk factor for car...
Familial Hypercholesterolemia (FH) is a genetic autosomal dominant disorder characterized clinically...
Familial Hypercholesterolaemia (FH) is the commonest autosomal co-dominantly inherited condition af...
The clinical phenotype of heterozygous familial hypercholesterolemia (FH) is characterized by increa...
Background: Clinically, Familial Hypercholesterolaemia (FH) is characterized by high plasma concentr...
textabstractFamilial hypercholesterolemia (FH) (OMIM #143890) is an autosomal dominant disorder pres...
Aim: Genetic diagnosis is the only method to correctly identify patients with Familial hypercholest...
Familial Hypercholesterolaemia (FH) is a monogenic disorder characterised by high LDL-C concentratio...
textabstractFamilial hypercholesterolemia (FH) is an autosomal dominant disorder of lipid metabolism...
amilial hypercholesterolaemia (FH) is a monogenic disorder of low-density lipoprotein (LDL) metaboli...
Familial Hypercholesterolaemia (FH) is genetic disorder touching up to 1 to 250 people, increasing t...